{"transactions":[{"id":4634464,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":74652,"kind":"person","name":"Macfarlane K. Angela","position":1,"cik":"0001865182","reported_name":"Macfarlane K. Angela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-10-03T01:00:37.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":55924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2026."}],"balance_after":55924,"derivative":{"exercise_price":1.55,"expiration_date":"2036-10-01","underlying":"Common Stock","underlying_shares":55924},"source":{"system":"sec-edgar","filing":"0001493152-26-045582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865182/000149315226045582/ownership.xml","form_type":"4"}},{"id":4634804,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":34255,"kind":"person","name":"Spiegel Robert J.","position":1,"cik":"0001492256","reported_name":"Spiegel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-10-03T01:00:33.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":55924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2026."}],"balance_after":55924,"derivative":{"exercise_price":1.55,"expiration_date":"2036-10-01","underlying":"Common Stock","underlying_shares":55924},"source":{"system":"sec-edgar","filing":"0001493152-26-045580","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492256/000149315226045580/ownership.xml","form_type":"4"}},{"id":4635096,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":35617,"kind":"person","name":"RYAN UNA S","position":1,"cik":"0001255349","reported_name":"RYAN UNA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-10-03T01:00:31.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":55924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2026."}],"balance_after":55924,"derivative":{"exercise_price":1.55,"expiration_date":"2036-10-01","underlying":"Common Stock","underlying_shares":55924},"source":{"system":"sec-edgar","filing":"0001493152-26-045578","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255349/000149315226045578/ownership.xml","form_type":"4"}},{"id":4634779,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":43884,"kind":"person","name":"Marton Laurence","position":1,"cik":"0001862192","reported_name":"Marton Laurence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-10-03T01:00:30.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":55924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2026."}],"balance_after":55924,"derivative":{"exercise_price":1.55,"expiration_date":"2036-10-01","underlying":"Common Stock","underlying_shares":55924},"source":{"system":"sec-edgar","filing":"0001493152-26-045577","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862192/000149315226045577/ownership.xml","form_type":"4"}},{"id":4617654,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":45171,"kind":"person","name":"VOLL MARK","position":1,"cik":"0001207512","reported_name":"VOLL MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-15T10:04:14.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The reported transaction involved the Reporting Person's receipt of a grant of 80,000 restricted stock units (\"RSUs\") for his future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction involved the Reporting Person's receipt of a grant of 80,000 restricted stock units (\"RSUs\") for his future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved the Reporting Person's receipt of a grant of 80,000 restricted stock units (\"RSUs\") for his future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed."}],"balance_after":222380,"source":{"system":"sec-edgar","filing":"0001493152-26-042650","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574094/000149315226042650/ownership.xml","form_type":"4"}},{"id":727486,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":35617,"kind":"person","name":"RYAN UNA S","position":1,"cik":"0001255349","reported_name":"RYAN UNA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T21:20:01.000Z","date":"2022-04-22","kind":"other","planned":false,"acquired":true,"shares":16206,"price":1.6215,"value":26278.029,"ownership":{"direct":false,"nature":"The Una S. Ryan Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects distribution from Golden Seeds Venture Fund GP, of which the reporting person is a non-managing member."}],"balance_after":97165,"source":{"system":"sec-edgar","filing":"0001493152-26-029958","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1255349/000149315226029958/ownership.xml","form_type":"4"}},{"id":727485,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":35617,"kind":"person","name":"RYAN UNA S","position":1,"cik":"0001255349","reported_name":"RYAN UNA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T21:20:01.000Z","date":"2022-04-22","kind":"other","planned":false,"acquired":true,"shares":26838,"price":0.9315,"value":24999.597,"ownership":{"direct":false,"nature":"The Una S. Ryan Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects distribution from Golden Seeds Venture Fund GP, of which the reporting person is a non-managing member."}],"balance_after":80959,"source":{"system":"sec-edgar","filing":"0001493152-26-029958","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1255349/000149315226029958/ownership.xml","form_type":"4"}},{"id":727484,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":35617,"kind":"person","name":"RYAN UNA S","position":1,"cik":"0001255349","reported_name":"RYAN UNA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T21:20:01.000Z","date":"2022-03-03","kind":"other","planned":false,"acquired":true,"shares":6332,"price":3.95,"value":25011.4,"ownership":{"direct":false,"nature":"The Una S. Ryan Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects distribution from Astria Fund, of which the reporting person is a non-managing member."}],"balance_after":54121,"source":{"system":"sec-edgar","filing":"0001493152-26-029958","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1255349/000149315226029958/ownership.xml","form_type":"4"}},{"id":727483,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":35617,"kind":"person","name":"RYAN UNA S","position":1,"cik":"0001255349","reported_name":"RYAN UNA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T21:20:01.000Z","date":"2022-03-03","kind":"other","planned":false,"acquired":true,"shares":47789,"price":4.19,"value":200235.91,"ownership":{"direct":false,"nature":"The Una S. Ryan Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects distribution from Astria Fund, of which the reporting person is a non-managing member."}],"balance_after":47789,"source":{"system":"sec-edgar","filing":"0001493152-26-029958","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255349/000149315226029958/ownership.xml","form_type":"4"}},{"id":767670,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":45171,"kind":"person","name":"VOLL MARK","position":1,"cik":"0001207512","reported_name":"VOLL MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-21T11:00:14.000Z","date":"2026-05-19","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":0.7876,"value":19690.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A grant of 58,953 restricted stock units (\"RSUs\") was previously reported for the Reporting Person's future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed. As of April 30, 2026, 8,823 of such RSUs had vested, leaving a remaining balance of 50,130 unvested RSUs."}],"balance_after":142380,"source":{"system":"sec-edgar","filing":"0001493152-26-024726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207512/000149315226024726/ownership.xml","form_type":"4"}},{"id":813519,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2026-04-08T00:00:06.000Z","date":"2026-04-03","kind":"grant","planned":false,"acquired":true,"shares":946107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 946,107 shares of the Issuer's common stock (111,621 shares of which are underlying incentive stock options and 834,486 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 946,107 shares of the Issuer's common stock (111,621 shares of which are underlying incentive stock options and 834,486 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036."}],"balance_after":946107,"derivative":{"exercise_price":0.98,"underlying":"Common Stock","underlying_shares":946107},"source":{"system":"sec-edgar","filing":"0001493152-26-015594","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315226015594/ownership.xml","form_type":"4"}},{"id":813242,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":45171,"kind":"person","name":"VOLL MARK","position":1,"cik":"0001207512","reported_name":"VOLL MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-08T00:00:05.000Z","date":"2026-04-03","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The reported transaction involved the Reporting Person's receipts of (i) a grant of 8,777 restricted stock units (\"RSUs\") for his service as the Chief Financial Officer of the Issuer for February 2026, which are fully vested upon grant, and (ii) a grant of 12,270 RSUs for his service as the Chief Financial Officer for March 2026, which are fully vested upon grant and (iii) a grant of 58,953 RSUs for his future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction involved the Reporting Person's receipts of (i) a grant of 8,777 restricted stock units (\"RSUs\") for his service as the Chief Financial Officer of the Issuer for February 2026, which are fully vested upon grant, and (ii) a grant of 12,270 RSUs for his service as the Chief Financial Officer for March 2026, which are fully vested upon grant and (iii) a grant of 58,953 RSUs for his future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved the Reporting Person's receipts of (i) a grant of 8,777 restricted stock units (\"RSUs\") for his service as the Chief Financial Officer of the Issuer for February 2026, which are fully vested upon grant, and (ii) a grant of 12,270 RSUs for his service as the Chief Financial Officer for March 2026, which are fully vested upon grant and (iii) a grant of 58,953 RSUs for his future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed."}],"balance_after":117380,"source":{"system":"sec-edgar","filing":"0001493152-26-015593","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207512/000149315226015593/ownership.xml","form_type":"4"}},{"id":813579,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53434,"kind":"person","name":"Gentry Leesa","position":1,"cik":"0002013097","reported_name":"Gentry Leesa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Stock Option","published_at":"2026-04-08T00:00:03.000Z","date":"2026-04-03","kind":"grant","planned":false,"acquired":true,"shares":128550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 128,550 shares of the Issuer's common stock (66,954 shares of which are underlying incentive stock options and 61,596 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 128,550 shares of the Issuer's common stock (66,954 shares of which are underlying incentive stock options and 61,596 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036."}],"balance_after":128550,"derivative":{"exercise_price":0.98,"underlying":"Common Stock","underlying_shares":128550},"source":{"system":"sec-edgar","filing":"0001493152-26-015592","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013097/000149315226015592/ownership.xml","form_type":"4"}},{"id":813513,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-04-08T00:00:02.000Z","date":"2026-04-03","kind":"grant","planned":false,"acquired":true,"shares":621727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 621,727 shares of the Issuer's common stock (319,073 shares of which are underlying incentive stock options and 302,654 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 621,727 shares of the Issuer's common stock (319,073 shares of which are underlying incentive stock options and 302,654 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036."}],"balance_after":621727,"derivative":{"exercise_price":0.98,"underlying":"Common Stock","underlying_shares":621727},"source":{"system":"sec-edgar","filing":"0001493152-26-015591","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000149315226015591/ownership.xml","form_type":"4"}},{"id":826252,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":45171,"kind":"person","name":"VOLL MARK","position":1,"cik":"0001207512","reported_name":"VOLL MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-27T11:32:10.000Z","date":"2026-03-25","kind":"grant","planned":false,"acquired":true,"shares":12380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction involved the Reporting Person's receipt of a grant of 12,380 restricted stock units for his service as a consultant of the Issuer for January 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved the Reporting Person's receipt of a grant of 12,380 restricted stock units for his service as a consultant of the Issuer for January 2026."}],"balance_after":37380,"source":{"system":"sec-edgar","filing":"0001493152-26-013083","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207512/000149315226013083/ownership.xml","form_type":"4"}},{"id":829450,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":43884,"kind":"person","name":"Marton Laurence","position":1,"cik":"0001862192","reported_name":"Marton Laurence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2026-03-25T01:16:57.000Z","date":"2026-03-20","kind":"purchase","planned":false,"acquired":true,"shares":4860,"ownership":{"direct":false,"nature":"Laurence Marton Rollover IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were purchased in a private placement on March 20, 2026 for an aggregate of $10,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report."}],"balance_after":4860,"derivative":{"exercise_price":1.9326,"underlying":"Common Stock","underlying_shares":4860},"source":{"system":"sec-edgar","filing":"0001493152-26-012483","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862192/000149315226012483/ownership.xml","form_type":"4"}},{"id":829449,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":43884,"kind":"person","name":"Marton Laurence","position":1,"cik":"0001862192","reported_name":"Marton Laurence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-25T01:16:57.000Z","date":"2026-03-20","kind":"purchase","planned":false,"acquired":true,"shares":9720,"ownership":{"direct":false,"nature":"Laurence Marton Rollover IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were purchased in a private placement on March 20, 2026 for an aggregate of $10,000."}],"balance_after":9720,"source":{"system":"sec-edgar","filing":"0001493152-26-012483","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862192/000149315226012483/ownership.xml","form_type":"4"}},{"id":829448,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants","published_at":"2026-03-25T01:16:41.000Z","date":"2026-03-20","kind":"purchase","planned":false,"acquired":true,"shares":12150,"ownership":{"direct":false,"nature":"The Bagai Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were purchased in a private placement on March 20, 2026 for an aggregate of $25,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report."}],"balance_after":12150,"derivative":{"exercise_price":1.9326,"underlying":"Common Stock","underlying_shares":12150},"source":{"system":"sec-edgar","filing":"0001493152-26-012482","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315226012482/ownership.xml","form_type":"4"}},{"id":829447,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-25T01:16:41.000Z","date":"2026-03-20","kind":"purchase","planned":false,"acquired":true,"shares":24300,"ownership":{"direct":false,"nature":"The Bagai Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were purchased in a private placement on March 20, 2026 for an aggregate of $25,000."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"289,057 shares of common stock are held of record by The Bagai Family Trust and were previously reported as \"directly\" beneficially held by the Reporting Person."}],"balance_after":313357,"source":{"system":"sec-edgar","filing":"0001493152-26-012482","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315226012482/ownership.xml","form_type":"4"}},{"id":829106,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":45171,"kind":"person","name":"VOLL MARK","position":1,"cik":"0001207512","reported_name":"VOLL MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants","published_at":"2026-03-25T01:15:56.000Z","date":"2026-03-20","kind":"purchase","planned":false,"acquired":true,"shares":48600,"ownership":{"direct":false,"nature":"Voll Family Trust DTD 6/23/2010 Mark Voll TTEE"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were purchased in a private placement on March 20, 2026 for an aggregate of $100,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report."}],"balance_after":48600,"derivative":{"exercise_price":1.9326,"underlying":"Common Stock","underlying_shares":48600},"source":{"system":"sec-edgar","filing":"0001493152-26-012481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207512/000149315226012481/ownership.xml","form_type":"4"}},{"id":829105,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":45171,"kind":"person","name":"VOLL MARK","position":1,"cik":"0001207512","reported_name":"VOLL MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-25T01:15:56.000Z","date":"2026-03-20","kind":"purchase","planned":false,"acquired":true,"shares":97200,"ownership":{"direct":false,"nature":"Voll Family Trust DTD 6/23/2010 Mark Voll TTEE"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were purchased in a private placement on March 20, 2026 for an aggregate of $100,000."}],"balance_after":97200,"source":{"system":"sec-edgar","filing":"0001493152-26-012481","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207512/000149315226012481/ownership.xml","form_type":"4"}},{"id":933474,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-22T12:00:18.000Z","date":"2026-01-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.9975,"value":9975.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $0.995 to $1.00."}],"balance_after":798460,"source":{"system":"sec-edgar","filing":"0001493152-26-003181","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000149315226003181/ownership.xml","form_type":"4"}},{"id":951876,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-05T12:00:02.000Z","date":"2025-12-31","kind":"purchase","planned":false,"acquired":true,"shares":9795,"price":0.86,"value":8423.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":788460,"source":{"system":"sec-edgar","filing":"0001493152-26-000255","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000149315226000255/ownership.xml","form_type":"4"}},{"id":955305,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-02T22:00:20.000Z","date":"2025-12-30","kind":"purchase","planned":false,"acquired":true,"shares":205,"price":0.826,"value":169.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $0.825 to $0.873."}],"balance_after":778665,"source":{"system":"sec-edgar","filing":"0001493152-26-000157","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000149315226000157/ownership.xml","form_type":"4"}},{"id":961107,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:00:23.000Z","date":"2025-12-18","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9013,"value":4506.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":340040,"source":{"system":"sec-edgar","filing":"0001493152-25-028650","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315225028650/ownership.xml","form_type":"4"}},{"id":962122,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-19T12:00:20.000Z","date":"2025-12-17","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.8524,"value":4262.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":335040,"source":{"system":"sec-edgar","filing":"0001493152-25-028439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315225028439/ownership.xml","form_type":"4"}},{"id":965275,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-17T12:00:18.000Z","date":"2025-12-16","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":0.85,"value":10200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an open market purchase of the Issuer's securities."}],"balance_after":778460,"source":{"system":"sec-edgar","filing":"0001493152-25-028057","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000149315225028057/ownership.xml","form_type":"4"}},{"id":977751,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-08T12:00:26.000Z","date":"2025-12-05","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.96,"value":9600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":766460,"source":{"system":"sec-edgar","filing":"0001493152-25-026516","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000149315225026516/ownership.xml","form_type":"4"}},{"id":990287,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-24T23:00:03.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":0.8,"value":9600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":756460,"source":{"system":"sec-edgar","filing":"0001493152-25-024875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000149315225024875/ownership.xml","form_type":"4"}},{"id":990286,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-24T23:00:03.000Z","date":"2025-11-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.8,"value":8000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":744460,"source":{"system":"sec-edgar","filing":"0001493152-25-024875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000149315225024875/ownership.xml","form_type":"4"}},{"id":1024796,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":43884,"kind":"person","name":"Marton Laurence","position":1,"cik":"0001862192","reported_name":"Marton Laurence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-10-03T13:19:39.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":47640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2025."}],"balance_after":47640,"derivative":{"exercise_price":1.34,"expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":47640},"source":{"system":"sec-edgar","filing":"0001493152-25-016789","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862192/000149315225016789/ownership.xml","form_type":"4"}},{"id":1026649,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":35617,"kind":"person","name":"RYAN UNA S","position":1,"cik":"0001255349","reported_name":"RYAN UNA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-10-03T00:17:41.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":47640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2025."}],"balance_after":47640,"derivative":{"exercise_price":1.34,"expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":47640},"source":{"system":"sec-edgar","filing":"0001493152-25-016758","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255349/000149315225016758/ownership.xml","form_type":"4"}},{"id":1027141,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":34255,"kind":"person","name":"Spiegel Robert J.","position":1,"cik":"0001492256","reported_name":"Spiegel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-10-03T00:10:30.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":47640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2025."}],"balance_after":47640,"derivative":{"exercise_price":1.34,"expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":47640},"source":{"system":"sec-edgar","filing":"0001493152-25-016756","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492256/000149315225016756/ownership.xml","form_type":"4"}},{"id":1027504,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":74652,"kind":"person","name":"Macfarlane K. Angela","position":1,"cik":"0001865182","reported_name":"Macfarlane K. Angela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-10-02T20:23:17.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":47640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2025."}],"balance_after":47640,"derivative":{"exercise_price":1.34,"expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":47640},"source":{"system":"sec-edgar","filing":"0001493152-25-016760","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865182/000149315225016760/ownership.xml","form_type":"4"}},{"id":1055841,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-26T10:10:14.000Z","date":"2025-08-25","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9098,"value":4549.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":330040,"source":{"system":"sec-edgar","filing":"0001641172-25-025459","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000164117225025459/ownership.xml","form_type":"4"}},{"id":1055840,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-26T10:10:14.000Z","date":"2025-08-22","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.9495,"value":4747.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":325040,"source":{"system":"sec-edgar","filing":"0001641172-25-025459","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000164117225025459/ownership.xml","form_type":"4"}},{"id":1092686,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2025-07-03T20:45:34.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":63636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of 63,636 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the \"Plan\") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025. The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents an award of 63,636 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the \"Plan\") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025. The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035."}],"balance_after":63636,"derivative":{"exercise_price":1.27,"underlying":"Common stock","underlying_shares":63636},"source":{"system":"sec-edgar","filing":"0001641172-25-017833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000164117225017833/ownership.xml","form_type":"4"}},{"id":1092687,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-07-03T20:45:33.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":102498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 21,072 incentive stock options and 81,426 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the \"Plan\") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an award of 21,072 incentive stock options and 81,426 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the \"Plan\") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025."}],"balance_after":102498,"derivative":{"exercise_price":1.27,"underlying":"Common Stock","underlying_shares":102498},"source":{"system":"sec-edgar","filing":"0001641172-25-017832","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000164117225017832/ownership.xml","form_type":"4"}},{"id":1092818,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53434,"kind":"person","name":"Gentry Leesa","position":1,"cik":"0002013097","reported_name":"Gentry Leesa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Stock Option","published_at":"2025-07-03T20:45:31.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":6619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 2,621 incentive stock options and 3,998 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the \"Plan\") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents an award of 2,621 incentive stock options and 3,998 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the \"Plan\") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025."}],"balance_after":6619,"derivative":{"exercise_price":1.27,"underlying":"Common Stock","underlying_shares":6619},"source":{"system":"sec-edgar","filing":"0001641172-25-017831","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013097/000164117225017831/ownership.xml","form_type":"4"}},{"id":1092817,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":77724,"kind":"person","name":"Kocak Ron","position":1,"cik":"0002011160","reported_name":"Kocak Ron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Stock Option","published_at":"2025-07-03T16:45:30.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":41600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of 41,600 incentive stock options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the \"Plan\") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025. The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents an award of 41,600 incentive stock options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the \"Plan\") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025. The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035."}],"balance_after":41600,"derivative":{"exercise_price":1.27,"underlying":"Common Stock","underlying_shares":41600},"source":{"system":"sec-edgar","filing":"0001641172-25-017830","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011160/000164117225017830/ownership.xml","form_type":"4"}},{"id":1118113,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-06-09T10:03:27.000Z","date":"2025-06-05","kind":"purchase","planned":false,"acquired":true,"shares":21000,"price":1.4,"value":29400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":734460,"source":{"system":"sec-edgar","filing":"0001641172-25-014212","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000164117225014212/ownership.xml","form_type":"4"}},{"id":1119900,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-06-06T21:15:19.000Z","date":"2025-04-22","kind":"gift","planned":false,"acquired":false,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 22, 2025, the reporting person made a bona fide gift of an aggregate of 400,000 shares of the Issuer's common stock to trusts for the benefit of the reporting person's children. The reporting person is not a trustee or beneficiary of such trusts and therefore no longer has a beneficial ownership interest in the subject shares."}],"balance_after":713460,"source":{"system":"sec-edgar","filing":"0001641172-25-014112","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000164117225014112/ownership.xml","form_type":"4"}},{"id":1157480,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":43884,"kind":"person","name":"Marton Laurence","position":1,"cik":"0001862192","reported_name":"Marton Laurence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-06T20:10:20.000Z","date":"2025-05-02","kind":"exercise","planned":false,"acquired":false,"shares":20480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the reporting person's cash exercise of an outstanding stock option into shares of common stock, with no sale of such shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.15,"expiration_date":"2025-10-14","underlying":"Common Stock","underlying_shares":20480},"source":{"system":"sec-edgar","filing":"0001641172-25-008842","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862192/000164117225008842/ownership.xml","form_type":"4"}},{"id":1157479,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":43884,"kind":"person","name":"Marton Laurence","position":1,"cik":"0001862192","reported_name":"Marton Laurence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-06T20:10:20.000Z","date":"2025-05-02","kind":"exercise","planned":false,"acquired":true,"shares":20480,"price":0.15,"value":3072.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the reporting person's cash exercise of an outstanding stock option into shares of common stock, with no sale of such shares of common stock."}],"balance_after":66164,"source":{"system":"sec-edgar","filing":"0001641172-25-008842","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862192/000164117225008842/ownership.xml","form_type":"4"}},{"id":1169898,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-17T10:10:32.000Z","date":"2025-04-15","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.9,"value":13500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":1113460,"source":{"system":"sec-edgar","filing":"0001641172-25-005139","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000164117225005139/ownership.xml","form_type":"4"}},{"id":1171070,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-04-16T21:18:21.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":true,"shares":409992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 409,992 shares of the Issuer's common stock (187,812 shares of which are underlying incentive stock options and 222,180 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2029, and will expire on April 14, 2035."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 409,992 shares of the Issuer's common stock (187,812 shares of which are underlying incentive stock options and 222,180 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2029, and will expire on April 14, 2035."}],"balance_after":409992,"derivative":{"exercise_price":0.8448,"underlying":"Common Stock","underlying_shares":409992},"source":{"system":"sec-edgar","filing":"0001641172-25-005107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000164117225005107/ownership.xml","form_type":"4"}},{"id":1171118,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53434,"kind":"person","name":"Gentry Leesa","position":1,"cik":"0002013097","reported_name":"Gentry Leesa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Stock Option","published_at":"2025-04-16T21:18:20.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":true,"shares":26477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 26,477 shares of the Issuer's common stock (7,173 shares of which are underlying incentive stock options and 19,304 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2029, and will expire on April 14, 2035."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 26,477 shares of the Issuer's common stock (7,173 shares of which are underlying incentive stock options and 19,304 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2029, and will expire on April 14, 2035."}],"balance_after":26477,"derivative":{"exercise_price":0.8448,"underlying":"Common Stock","underlying_shares":26477},"source":{"system":"sec-edgar","filing":"0001641172-25-005108","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013097/000164117225005108/ownership.xml","form_type":"4"}},{"id":1171068,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2025-04-16T21:18:17.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":true,"shares":254542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted a non-qualified stock option to purchase up to 254,542 shares of the Issuer's common stock, with such option vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on April 14, 2035.."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted a non-qualified stock option to purchase up to 254,542 shares of the Issuer's common stock, with such option vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on April 14, 2035.."}],"balance_after":254542,"derivative":{"exercise_price":0.8448,"underlying":"Common Stock","underlying_shares":254542},"source":{"system":"sec-edgar","filing":"0001641172-25-005106","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000164117225005106/ownership.xml","form_type":"4"}},{"id":1171117,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":77724,"kind":"person","name":"Kocak Ron","position":1,"cik":"0002011160","reported_name":"Kocak Ron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Stock Option","published_at":"2025-04-16T17:18:18.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":true,"shares":166400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted an incentive stock option to purchase up to 166,400 shares of the Issuer's common stock, with such option vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on April 14, 2035."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted an incentive stock option to purchase up to 166,400 shares of the Issuer's common stock, with such option vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on April 14, 2035."}],"balance_after":166400,"derivative":{"exercise_price":0.8448,"underlying":"Common Stock","underlying_shares":166400},"source":{"system":"sec-edgar","filing":"0001641172-25-005109","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011160/000164117225005109/ownership.xml","form_type":"4"}},{"id":1171069,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-16T10:08:22.000Z","date":"2025-04-15","kind":"purchase","planned":false,"acquired":true,"shares":7500,"price":0.9095,"value":6821.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":320040,"source":{"system":"sec-edgar","filing":"0001641172-25-004955","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000164117225004955/ownership.xml","form_type":"4"}},{"id":1172654,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-14T10:30:30.000Z","date":"2025-04-11","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.8,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":1098460,"source":{"system":"sec-edgar","filing":"0001641172-25-003951","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000164117225003951/ownership.xml","form_type":"4"}},{"id":1174144,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-10T20:30:23.000Z","date":"2025-04-09","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":0.8133,"value":24399.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":1078460,"source":{"system":"sec-edgar","filing":"0001641172-25-003631","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000164117225003631/ownership.xml","form_type":"4"}},{"id":1174218,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":77724,"kind":"person","name":"Kocak Ron","position":1,"cik":"0002011160","reported_name":"Kocak Ron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller and PAO"}}],"security":"Common Stock","published_at":"2025-04-10T19:02:33.000Z","date":"2025-04-10","kind":"purchase","planned":false,"acquired":true,"shares":6500,"price":0.79,"value":5135.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":12595,"source":{"system":"sec-edgar","filing":"0001641172-25-003675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2011160/000164117225003675/ownership.xml","form_type":"4"}},{"id":1174217,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":77724,"kind":"person","name":"Kocak Ron","position":1,"cik":"0002011160","reported_name":"Kocak Ron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller and PAO"}}],"security":"Common Stock","published_at":"2025-04-10T19:02:33.000Z","date":"2025-04-09","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":0.8,"value":4800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":6095,"source":{"system":"sec-edgar","filing":"0001641172-25-003675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2011160/000164117225003675/ownership.xml","form_type":"4"}},{"id":1174216,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":77724,"kind":"person","name":"Kocak Ron","position":1,"cik":"0002011160","reported_name":"Kocak Ron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Controller and PAO"}}],"security":"Common Stock","published_at":"2025-04-10T19:02:33.000Z","date":"2025-04-08","kind":"purchase","planned":false,"acquired":true,"shares":95,"price":0.8,"value":76.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."}],"balance_after":95,"source":{"system":"sec-edgar","filing":"0001641172-25-003675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011160/000164117225003675/ownership.xml","form_type":"4"}},{"id":1174146,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-10T10:02:18.000Z","date":"2025-04-09","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.83,"value":8300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.82795 to $0.829, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":312540,"source":{"system":"sec-edgar","filing":"0001641172-25-003504","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000164117225003504/ownership.xml","form_type":"4"}},{"id":1174774,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":43884,"kind":"person","name":"Marton Laurence","position":1,"cik":"0001862192","reported_name":"Marton Laurence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-10T01:30:37.000Z","date":"2025-04-08","kind":"purchase","planned":false,"acquired":true,"shares":12050,"price":0.848,"value":10218.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an open market purchase of the Issuer's securities."}],"balance_after":45684,"source":{"system":"sec-edgar","filing":"0001641172-25-003496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862192/000164117225003496/ownership.xml","form_type":"4"}},{"id":1174773,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-09T16:45:33.000Z","date":"2025-04-08","kind":"purchase","planned":false,"acquired":true,"shares":26000,"price":0.84,"value":21840.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.825 to $0.8499, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 975,000 shares, which are held of record by the reporting person currently and were held of record by the Mars16 Nevada Non-Grantor Trust Dtd 01/19/2016 and reported as indirectly held by the reporting person previously."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Includes 975,000 shares, which are held of record by the reporting person currently and were held of record by the Mars16 Nevada Non-Grantor Trust Dtd 01/19/2016 and reported as indirectly held by the reporting person previously."}],"balance_after":1048460,"source":{"system":"sec-edgar","filing":"0001641172-25-003364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000164117225003364/ownership.xml","form_type":"4"}},{"id":1175713,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-08T15:30:03.000Z","date":"2025-04-07","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.83,"value":8300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects open market purchases of the Issuer's securities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.816 to $0.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":302540,"source":{"system":"sec-edgar","filing":"0001641172-25-003158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000164117225003158/ownership.xml","form_type":"4"}},{"id":1393904,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":35617,"kind":"person","name":"RYAN UNA S","position":1,"cik":"0001255349","reported_name":"RYAN UNA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2024-10-02T20:30:19.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":25099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2024."}],"balance_after":25099,"derivative":{"exercise_price":1.02,"expiration_date":"2034-10-01","underlying":"Common Stock","underlying_shares":25099},"source":{"system":"sec-edgar","filing":"0001493152-24-039214","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255349/000149315224039214/ownership.xml","form_type":"4"}},{"id":1394713,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":43884,"kind":"person","name":"Marton Laurence","position":1,"cik":"0001862192","reported_name":"Marton Laurence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2024-10-02T20:30:17.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":25099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2024."}],"balance_after":25099,"derivative":{"exercise_price":1.02,"expiration_date":"2034-10-01","underlying":"Common Stock","underlying_shares":25099},"source":{"system":"sec-edgar","filing":"0001493152-24-039217","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862192/000149315224039217/ownership.xml","form_type":"4"}},{"id":1394389,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":34255,"kind":"person","name":"Spiegel Robert J.","position":1,"cik":"0001492256","reported_name":"Spiegel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2024-10-02T20:30:15.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":25099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2024."}],"balance_after":25099,"derivative":{"exercise_price":1.02,"expiration_date":"2034-10-01","underlying":"Common Stock","underlying_shares":25099},"source":{"system":"sec-edgar","filing":"0001493152-24-039216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492256/000149315224039216/ownership.xml","form_type":"4"}},{"id":1394741,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":74652,"kind":"person","name":"Macfarlane K. Angela","position":1,"cik":"0001865182","reported_name":"Macfarlane K. Angela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2024-10-02T16:30:18.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":25099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2024."}],"balance_after":25099,"derivative":{"exercise_price":1.02,"expiration_date":"2034-10-01","underlying":"Common Stock","underlying_shares":25099},"source":{"system":"sec-edgar","filing":"0001493152-24-039213","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865182/000149315224039213/ownership.xml","form_type":"4"}},{"id":1587252,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53434,"kind":"person","name":"Gentry Leesa","position":1,"cik":"0002013097","reported_name":"Gentry Leesa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Options","published_at":"2024-03-08T21:28:31.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":190000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents 10-year incentive stock options to purchase 190,000 shares of the Company's common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. These options vest over four years at a rate of 1/48 per month, beginning to vest on March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents 10-year incentive stock options to purchase 190,000 shares of the Company's common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. These options vest over four years at a rate of 1/48 per month, beginning to vest on March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents 10-year incentive stock options to purchase 190,000 shares of the Company's common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. These options vest over four years at a rate of 1/48 per month, beginning to vest on March 1, 2024."}],"balance_after":190000,"derivative":{"exercise_price":1.69,"underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001493152-24-009409","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013097/000149315224009409/ownership.xml","form_type":"4"}},{"id":1649673,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":77724,"kind":"person","name":"Kocak Ron","position":1,"cik":"0002011160","reported_name":"Kocak Ron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Controller and PAO"}}],"security":"Options","published_at":"2024-02-12T19:46:10.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents 10-year incentive stock options to purchase 15,000 shares of the Company's common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. These options vest over four years at a rate of 1/48 per month, beginning vesting on the date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents 10-year incentive stock options to purchase 15,000 shares of the Company's common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. These options vest over four years at a rate of 1/48 per month, beginning vesting on the date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents 10-year incentive stock options to purchase 15,000 shares of the Company's common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. These options vest over four years at a rate of 1/48 per month, beginning vesting on the date."}],"balance_after":15000,"derivative":{"exercise_price":1.59,"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-24-005939","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011160/000149315224005939/ownership.xml","form_type":"4"}},{"id":1666705,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Warrants","published_at":"2024-01-31T00:33:47.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":40983,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. These warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. These warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. These warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."}],"balance_after":40983,"derivative":{"exercise_price":1.22,"underlying":"Common Stock","underlying_shares":40983},"source":{"system":"sec-edgar","filing":"0001493152-24-004372","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000149315224004372/ownership.xml","form_type":"4"}},{"id":1666704,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-31T00:33:47.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":40983,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. These warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."}],"balance_after":47460,"source":{"system":"sec-edgar","filing":"0001493152-24-004372","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000149315224004372/ownership.xml","form_type":"4"}},{"id":1666452,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":34255,"kind":"person","name":"Spiegel Robert J.","position":1,"cik":"0001492256","reported_name":"Spiegel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2024-01-31T00:00:16.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":40983,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."}],"balance_after":40983,"derivative":{"exercise_price":1.22,"underlying":"Common Stock","underlying_shares":40983},"source":{"system":"sec-edgar","filing":"0001493152-24-004370","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492256/000149315224004370/ownership.xml","form_type":"4"}},{"id":1666451,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":34255,"kind":"person","name":"Spiegel Robert J.","position":1,"cik":"0001492256","reported_name":"Spiegel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-31T00:00:16.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":40983,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."}],"balance_after":40983,"source":{"system":"sec-edgar","filing":"0001493152-24-004370","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492256/000149315224004370/ownership.xml","form_type":"4"}},{"id":1666707,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants","published_at":"2024-01-30T23:57:58.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":40983,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."}],"balance_after":40983,"derivative":{"exercise_price":1.22,"underlying":"Common Stock","underlying_shares":40983},"source":{"system":"sec-edgar","filing":"0001493152-24-004368","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315224004368/ownership.xml","form_type":"4"}},{"id":1666706,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-30T23:57:58.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":40983,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."}],"balance_after":292540,"source":{"system":"sec-edgar","filing":"0001493152-24-004368","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315224004368/ownership.xml","form_type":"4"}},{"id":1666709,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":43884,"kind":"person","name":"Marton Laurence","position":1,"cik":"0001862192","reported_name":"Marton Laurence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2024-01-30T23:32:23.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":8196,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 8,196 shares of common stock and warrants to purchase 8,196 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person purchased 8,196 shares of common stock and warrants to purchase 8,196 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reporting Person purchased 8,196 shares of common stock and warrants to purchase 8,196 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."}],"balance_after":8196,"derivative":{"exercise_price":1.22,"underlying":"Common Stock","underlying_shares":8196},"source":{"system":"sec-edgar","filing":"0001493152-24-004366","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862192/000149315224004366/ownership.xml","form_type":"4"}},{"id":1666708,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":43884,"kind":"person","name":"Marton Laurence","position":1,"cik":"0001862192","reported_name":"Marton Laurence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-30T23:32:23.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":8196,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 8,196 shares of common stock and warrants to purchase 8,196 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."}],"balance_after":33634,"source":{"system":"sec-edgar","filing":"0001493152-24-004366","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862192/000149315224004366/ownership.xml","form_type":"4"}},{"id":1666716,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":74652,"kind":"person","name":"Macfarlane K. Angela","position":1,"cik":"0001865182","reported_name":"Macfarlane K. Angela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant Shares","published_at":"2024-01-30T18:30:25.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":40983,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."}],"balance_after":40983,"derivative":{"exercise_price":1.22,"underlying":"Common Stock","underlying_shares":40983},"source":{"system":"sec-edgar","filing":"0001493152-24-004364","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865182/000149315224004364/ownership.xml","form_type":"4"}},{"id":1666715,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":74652,"kind":"person","name":"Macfarlane K. Angela","position":1,"cik":"0001865182","reported_name":"Macfarlane K. Angela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-30T18:30:25.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":40983,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029."}],"balance_after":40983,"source":{"system":"sec-edgar","filing":"0001493152-24-004364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865182/000149315224004364/ownership.xml","form_type":"4"}},{"id":1672724,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":94981,"kind":"person","name":"Nelms Angela","position":1,"cik":"0001946374","reported_name":"Nelms Angela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2024-01-24T02:50:30.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":125132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 19, 2024, the Reporting Person received a nonqualified stock option grant for a total of 125,132 shares of common stock vesting over four years at a rate of 1/48 per month with no cliff, beginning vesting on February 1, 2024. The option will become fully vested and exercisable on February 1, 2028, and expires on January, 19, 2034."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 19, 2024, the Reporting Person received a nonqualified stock option grant for a total of 125,132 shares of common stock vesting over four years at a rate of 1/48 per month with no cliff, beginning vesting on February 1, 2024. The option will become fully vested and exercisable on February 1, 2028, and expires on January, 19, 2034."}],"balance_after":125132,"derivative":{"exercise_price":1.08,"underlying":"Common Stock","underlying_shares":125132},"source":{"system":"sec-edgar","filing":"0001493152-24-003519","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1574094/000149315224003519/ownership.xml","form_type":"4"}},{"id":1672723,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":94981,"kind":"person","name":"Nelms Angela","position":1,"cik":"0001946374","reported_name":"Nelms Angela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2024-01-24T02:50:30.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":33768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 19, 2024, the Reporting Person was awarded a stock bonus of 33,768 shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan (the \"Plan\"). These shares were fully vested upon issuance to the Reporting Person, and expire on January 19, 2034."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 19, 2024, the Reporting Person was awarded a stock bonus of 33,768 shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan (the \"Plan\"). These shares were fully vested upon issuance to the Reporting Person, and expire on January 19, 2034."}],"balance_after":33768,"derivative":{"exercise_price":1.08,"underlying":"Common Stock","underlying_shares":33768},"source":{"system":"sec-edgar","filing":"0001493152-24-003519","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574094/000149315224003519/ownership.xml","form_type":"4"}},{"id":1673192,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2024-01-24T02:50:29.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":125132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 19, 2024, the Reporting Person received a nonqualified stock option grant for 125,132 shares of common stock vesting over four years at a rate of 1/48 per month with no cliff, beginning vesting on February 1, 2024. The option will become fully vested and exercisable on February 1, 2028, and expires on January 19, 2034."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 19, 2024, the Reporting Person received a nonqualified stock option grant for 125,132 shares of common stock vesting over four years at a rate of 1/48 per month with no cliff, beginning vesting on February 1, 2024. The option will become fully vested and exercisable on February 1, 2028, and expires on January 19, 2034."}],"balance_after":125132,"derivative":{"exercise_price":1.08,"underlying":"Common Stock","underlying_shares":125132},"source":{"system":"sec-edgar","filing":"0001493152-24-003520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000149315224003520/ownership.xml","form_type":"4"}},{"id":1673191,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2024-01-24T02:50:29.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":28424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 19, 2024, the Reporting Person was awarded a stock bonus of 28,424 shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan (the \"Plan\"). These shares were fully vested upon issuance to the Reporting Person, and expire on January 19, 2034."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 19, 2024, the Reporting Person was awarded a stock bonus of 28,424 shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan (the \"Plan\"). These shares were fully vested upon issuance to the Reporting Person, and expire on January 19, 2034."}],"balance_after":28424,"derivative":{"exercise_price":1.08,"underlying":"Common Stock","underlying_shares":28424},"source":{"system":"sec-edgar","filing":"0001493152-24-003520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000149315224003520/ownership.xml","form_type":"4"}},{"id":1673194,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-01-24T02:50:23.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":250263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 19, 2024, the Reporting Person received a nonqualified stock option grant for a total of 250,263 shares of common stock vesting over four years at a rate of 1/48 per month with no cliff, beginning vesting on February 1, 2024. The option will become fully vested and exercisable on February 1, 2028, and expires on January 19, 2034."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 19, 2024, the Reporting Person received a nonqualified stock option grant for a total of 250,263 shares of common stock vesting over four years at a rate of 1/48 per month with no cliff, beginning vesting on February 1, 2024. The option will become fully vested and exercisable on February 1, 2028, and expires on January 19, 2034."}],"balance_after":250263,"derivative":{"exercise_price":1.08,"underlying":"Common Stock","underlying_shares":250263},"source":{"system":"sec-edgar","filing":"0001493152-24-003521","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315224003521/ownership.xml","form_type":"4"}},{"id":1673193,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-01-24T02:50:23.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":66973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 19, 2024, the Reporting Person was awarded a stock bonus of 66,973 shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan (the \"Plan\"). These shares were fully vested upon issuance to the Reporting Person, expires on January 19, 2034."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 19, 2024, the Reporting Person was awarded a stock bonus of 66,973 shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan (the \"Plan\"). These shares were fully vested upon issuance to the Reporting Person, expires on January 19, 2034."}],"balance_after":66973,"derivative":{"exercise_price":1.08,"underlying":"Common Stock","underlying_shares":66973},"source":{"system":"sec-edgar","filing":"0001493152-24-003521","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315224003521/ownership.xml","form_type":"4"}},{"id":1764922,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":94981,"kind":"person","name":"Nelms Angela","position":1,"cik":"0001946374","reported_name":"Nelms Angela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-10-04T20:44:34.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":800,"price":1.045,"value":836.0,"ownership":{"direct":true},"balance_after":1100,"source":{"system":"sec-edgar","filing":"0001493152-23-035684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1574094/000149315223035684/ownership.xml","form_type":"4"}},{"id":1764921,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":94981,"kind":"person","name":"Nelms Angela","position":1,"cik":"0001946374","reported_name":"Nelms Angela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-10-04T20:44:34.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":1.0499,"value":314.97,"ownership":{"direct":true},"balance_after":300,"source":{"system":"sec-edgar","filing":"0001493152-23-035684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574094/000149315223035684/ownership.xml","form_type":"4"}},{"id":1770348,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":34255,"kind":"person","name":"Spiegel Robert J.","position":1,"cik":"0001492256","reported_name":"Spiegel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-10-02T20:15:58.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":25099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2023"}],"balance_after":25099,"derivative":{"exercise_price":1.33,"expiration_date":"2033-10-01","underlying":"Common Stock","underlying_shares":25099},"source":{"system":"sec-edgar","filing":"0001493152-23-035037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492256/000149315223035037/ownership.xml","form_type":"4"}},{"id":1770582,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":43884,"kind":"person","name":"Marton Laurence","position":1,"cik":"0001862192","reported_name":"Marton Laurence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-10-02T20:15:56.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":25099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2023"}],"balance_after":25099,"derivative":{"exercise_price":1.33,"expiration_date":"2033-10-01","underlying":"Common Stock","underlying_shares":25099},"source":{"system":"sec-edgar","filing":"0001493152-23-035035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862192/000149315223035035/ownership.xml","form_type":"4"}},{"id":1770225,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":35617,"kind":"person","name":"RYAN UNA S","position":1,"cik":"0001255349","reported_name":"RYAN UNA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-10-02T20:15:53.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":25099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2023"}],"balance_after":25099,"derivative":{"exercise_price":1.33,"expiration_date":"2033-10-01","underlying":"Common Stock","underlying_shares":25099},"source":{"system":"sec-edgar","filing":"0001493152-23-035036","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255349/000149315223035036/ownership.xml","form_type":"4"}},{"id":1770549,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":109313,"kind":"person","name":"Diamond David","position":1,"cik":"0001802807","reported_name":"Diamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-10-02T16:15:49.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":25099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2023"}],"balance_after":25099,"derivative":{"exercise_price":1.33,"expiration_date":"2033-10-01","underlying":"Common Stock","underlying_shares":25099},"source":{"system":"sec-edgar","filing":"0001493152-23-035033","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802807/000149315223035033/ownership.xml","form_type":"4"}},{"id":1770587,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":74652,"kind":"person","name":"Macfarlane K. Angela","position":1,"cik":"0001865182","reported_name":"Macfarlane K. Angela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-10-02T16:15:45.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":25099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2023"}],"balance_after":25099,"derivative":{"exercise_price":1.33,"expiration_date":"2033-10-01","underlying":"Common Stock","underlying_shares":25099},"source":{"system":"sec-edgar","filing":"0001493152-23-035034","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865182/000149315223035034/ownership.xml","form_type":"4"}},{"id":1912258,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":34255,"kind":"person","name":"Spiegel Robert J.","position":1,"cik":"0001492256","reported_name":"Spiegel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-27T20:43:09.000Z","date":"2023-04-25","kind":"grant","planned":false,"acquired":true,"shares":43026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 36 monthly installments beginning on May 25, 2023."}],"balance_after":43026,"derivative":{"exercise_price":2.74,"expiration_date":"2033-04-25","underlying":"Common Stock","underlying_shares":43026},"source":{"system":"sec-edgar","filing":"0001493152-23-013843","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492256/000149315223013843/ownership.xml","form_type":"4"}},{"id":1935864,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-29T20:57:57.000Z","date":"2023-03-15","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 48 equal monthly installments beginning on January 1, 2023."}],"balance_after":65000,"derivative":{"exercise_price":3.29,"expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001493152-23-009504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000149315223009504/ownership.xml","form_type":"4"}},{"id":1935865,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53426,"kind":"person","name":"Bagai Shaun","position":1,"cik":"0001862613","reported_name":"Bagai Shaun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-29T20:55:52.000Z","date":"2023-03-15","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 48 equal monthly installments beginning on January 1, 2023."}],"balance_after":130000,"derivative":{"exercise_price":3.29,"expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001493152-23-009494","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862613/000149315223009494/ownership.xml","form_type":"4"}},{"id":1935530,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":94981,"kind":"person","name":"Nelms Angela","position":1,"cik":"0001946374","reported_name":"Nelms Angela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-29T20:54:12.000Z","date":"2023-03-15","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 48 equal monthly installments beginning on January 1, 2023."}],"balance_after":32500,"derivative":{"exercise_price":3.29,"expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001493152-23-009489","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574094/000149315223009489/ownership.xml","form_type":"4"}},{"id":2124602,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":43884,"kind":"person","name":"Marton Laurence","position":1,"cik":"0001862192","reported_name":"Marton Laurence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-04T20:48:48.000Z","date":"2022-11-03","kind":"exercise","acquired":false,"shares":25438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option are fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.7,"expiration_date":"2023-04-02","underlying":"Common Stock","underlying_shares":25438},"source":{"system":"sec-edgar","filing":"0001209191-22-055815","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862192/000120919122055815/doc4.xml","form_type":"4"}},{"id":2124601,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":43884,"kind":"person","name":"Marton Laurence","position":1,"cik":"0001862192","reported_name":"Marton Laurence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-04T20:48:48.000Z","date":"2022-11-03","kind":"exercise","acquired":true,"shares":25438,"price":1.7,"value":43244.6,"ownership":{"direct":true},"balance_after":25438,"source":{"system":"sec-edgar","filing":"0001209191-22-055815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862192/000120919122055815/doc4.xml","form_type":"4"}},{"id":2143954,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":35617,"kind":"person","name":"RYAN UNA S","position":1,"cik":"0001255349","reported_name":"RYAN UNA S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-04T20:44:22.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":25099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2022."}],"balance_after":25099,"derivative":{"exercise_price":2.02,"expiration_date":"2032-10-01","underlying":"Common Stock","underlying_shares":25099},"source":{"system":"sec-edgar","filing":"0001209191-22-052309","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1255349/000120919122052309/doc4.xml","form_type":"4"}},{"id":2145034,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":43884,"kind":"person","name":"Marton Laurence","position":1,"cik":"0001862192","reported_name":"Marton Laurence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-04T20:36:51.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":25099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2022."}],"balance_after":25099,"derivative":{"exercise_price":2.02,"expiration_date":"2032-10-01","underlying":"Common Stock","underlying_shares":25099},"source":{"system":"sec-edgar","filing":"0001209191-22-052262","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862192/000120919122052262/doc4.xml","form_type":"4"}},{"id":2145046,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":74652,"kind":"person","name":"Macfarlane K. Angela","position":1,"cik":"0001865182","reported_name":"Macfarlane K. Angela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-04T16:30:05.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":25099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2022."}],"balance_after":25099,"derivative":{"exercise_price":2.02,"expiration_date":"2032-10-01","underlying":"Common Stock","underlying_shares":25099},"source":{"system":"sec-edgar","filing":"0001209191-22-052244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865182/000120919122052244/doc4.xml","form_type":"4"}},{"id":2144883,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":109313,"kind":"person","name":"Diamond David","position":1,"cik":"0001802807","reported_name":"Diamond David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-04T16:27:10.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":25099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2022."}],"balance_after":25099,"derivative":{"exercise_price":2.02,"expiration_date":"2032-10-01","underlying":"Common Stock","underlying_shares":25099},"source":{"system":"sec-edgar","filing":"0001209191-22-052234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802807/000120919122052234/doc4.xml","form_type":"4"}},{"id":2153329,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":94981,"kind":"person","name":"Nelms Angela","position":1,"cik":"0001946374","reported_name":"Nelms Angela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-09-21T20:14:02.000Z","date":"2022-09-19","kind":"grant","acquired":true,"shares":274230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the option vest on September 19, 2023 and 1/36th of the remaining shares vest monthly thereafter."}],"balance_after":274230,"derivative":{"exercise_price":2.42,"expiration_date":"2032-09-19","underlying":"Common Stock","underlying_shares":274230},"source":{"system":"sec-edgar","filing":"0001209191-22-050898","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574094/000120919122050898/doc4.xml","form_type":"4"}},{"id":2228223,"issuer":{"id":6797,"kind":"organization","name":"RenovoRx, Inc.","symbol":"RNXT"},"owners":[{"id":53425,"kind":"person","name":"Agah Ramtin","position":1,"cik":"0001862617","reported_name":"Agah Ramtin","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Warrants (right to buy)","published_at":"2022-06-17T20:06:13.000Z","date":"2021-08-30","kind":"exercise","acquired":true,"shares":1295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock underlying the warrant are immediately exercisable."}],"balance_after":1295,"derivative":{"exercise_price":10.8,"expiration_date":"2026-08-30","underlying":"Common Stock","underlying_shares":1295},"source":{"system":"sec-edgar","filing":"0001493152-22-017155","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1862617/000149315222017155/ownership.xml","form_type":"4"}}],"next_cursor":"2022-06-17T20:06:13.000000Z,2228223"}